CCR2 and ovarian carcinoma: Levina et al. revealed that CCL11 potently stimulated proliferation and migration/invasion of ovarian carcinoma cell lines, and these effects were inhibited by neutralizing antibodies against its cognate receptors (CCR2, 3, and 5) [34].